At least 20 million doses accessible by the end of September, when widespread vaccination campaigns mostly establish

Additional manufacturing character recently approved by FDA for Fluvirin pre-filled syringes

BASEL, Switzerland, August 7, 2008 – Novartis announced today that it started shipments of its Fluvirin® Influenza Virus Vaccine to US vigorousness trouble facilities and practitioners for the 2008/2009 [url=]viagra kaufen[/url] season.

The New Zealand is producing up to 40 million doses of Fluvirin, with the [url=]viagra rezeptfrei kaufen[/url] [url=]viagra kaufen[/url] categorizing recommended revolution in all three virus strains included in the influenza vaccine composition[1]. This year’s influenza vaccine contains the following three strains of the influenza virus